|
|
|
Volumn 23, Issue 5 SUPPL. 10, 1996, Pages 99-100
|
|
Gemcitabine: We've reached the end of the beginning
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
CISPLATIN;
CYTARABINE;
DNA;
DOCETAXEL;
GEMCITABINE;
IRINOTECAN;
NAVELBINE;
PACLITAXEL;
ANTINEOPLASTIC ACTIVITY;
BONE MARROW SUPPRESSION;
CANCER SURVIVAL;
CLINICAL TRIAL;
DNA DAMAGE;
HUMAN;
PAIN;
PANCREAS CANCER;
PHASE 1 CLINICAL TRIAL;
PHASE 2 CLINICAL TRIAL;
PHASE 3 CLINICAL TRIAL;
PRIORITY JOURNAL;
RADIOSENSITIZATION;
SHORT SURVEY;
ANTIMETABOLITES, ANTINEOPLASTIC;
DEOXYCYTIDINE;
HUMANS;
NEOPLASMS;
|
|
EID: 0029806616
PISSN: 00937754
EISSN: None
Source Type: Journal
DOI: None Document Type: Short Survey |
|
Times cited : (2)
|
|
References (0)
|
